share_log

Bright Minds Biosciences | 6-K: Condensed Consolidated Interim Financial Statements for the three and nine months ended June 30, 2023 and 2022

SEC announcement ·  Aug 14, 2023 19:07
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more